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Notch1 but Not Notch2 Is Essential for Generating
Hematopoietic Stem Cells from Endothelial Cells
due to defects in definitive hematopoiesis but not in
primitive hematopoiesis, the mechanism of definitive
hematopoiesis regulation is largely unknown.
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The Notch gene family is highly conserved from theTomoyuki Yamaguchi,1 Shigeo Masuda,1
nematode through the vertebrates (Artavanis-TsakonasKiyoshi Shimizu,1 Tokiharu Takahashi,1
et al., 1999) and plays an important role in determiningSeishi Ogawa,1 Yoshio Hamada,3 and Hisamaru Hirai1,*
cell fate in multiple systems. In vertebrates, four mem-1Department of Hematology and Oncology
bers of this gene family, Notch1 through Notch4, have2 Cardiovascular Medicine
been isolated (Ellisen et al., 1991; Weinmaster et al.,Graduate School of Medicine
1992; Lardelli et al., 1994; Uyttendaele et al., 1996).University of Tokyo
Among the Notch family proteins, Notch1 and Notch27-3-1 Hongo, Bunkyo-ku
have been shown to be expressed in the hematopoieticTokyo 113-8655
progenitor cells (Milner et al., 1994; Bigas et al., 1998).3 National Institute of Basic Biology
Infection of mouse bone marrow cells with a retrovirusOkazaki, Aichi 444-8585
containing a constitutive active form of Notch1 resultedJapan
in the establishment of immortalized, cytokine-depen-
dent cell lines that generated progeny with either
lymphoid or myeloid characteristics both in vitro and inSummary
vivo (Varnum-Finney et al., 2000). Furthermore, Notch
ligands, Jagged1, Jagged2, and Delta1, can inhibit dif-Hematopoietic stem cells (HSCs) are thought to arise
ferentiation of hematopoietic progenitor cells (Varnum-in the aorta-gonad-mesonephros (AGM) region of em-
Finney et al., 1998; Jones et al., 1998; Carlesso et al.,bryo proper, although HSC activity can be detected in
1999; Han et al., 2000). Finally, Jagged1 was recentlyyolk sac (YS) and paraaortic splanchnopleura (P-Sp)
shown to be a novel growth factor for hematopoieticwhen transplanted in newborn mice. We examined the
stem cells (Karanu et al., 2000). When these findingsrole of Notch signaling in embryonic hematopoiesis.
are taken together, the Notch signal is likely to preventThe activity of colony-forming cells in the YS from
hematopoietic progenitor cells from differentiating.Notch1/ embryos was comparable to that of wild-
However, in a recent report on the phenotype of Notch1-type embryos. However, in vitro and in vivo definitive
conditional knockout mice, in which Notch1 was dis-hematopoietic activities from YS and P-Sp were se-
rupted after birth, only T cell developmental deficiencyverely impaired in Notch1/ embryos. The population
was observed, while nonlymphoid hematopoiesis wasrepresenting hemogenic endothelial cells, however,
apparently normal (Radtke et al., 1999).did not decrease. In contrast, Notch2/ embryos
Recently, Notch1 and Notch4 have been shown toshowed no hematopoietic deficiency. These data indi-
be essential for vascular morphogenesis, especially incate that Notch1, but not Notch2, is essential for gen-
angiogenesis (Krebs et al., 2000). The development oferating hematopoietic stem cells from endothelial
hematopoietic cells is closely related to angiogenesis,cells.
indicating the existence of hemangioblasts and hemo-
genic endothelial cells. There is evidence supporting theIntroduction
existence of hemangioblast in YS (Choi et al., 1998).
Within the embryo proper, the origin of the definitive
During mouse embryogenesis, hematopoiesis begins in
hematopoietic cells was pinpointed to the dorsal aorta,
the yolk sac (YS) blood island at embryonic day (E)7.5
where budding of hematopoietic cells from endothelial
and then shifts to the fetal liver after E11.5 and later cells was observed histologically (de Bruijn et al., 2000).
to spleen and bone marrow. Hematopoiesis before the In mice heterozygous for the knockin allele of Runx1
formation of the fetal liver is known as primitive hemato- with lacZ, lacZ staining was detected in the endothelial
poiesis, and consists of mainly nucleated erythrocytes cells of the dorsal aorta and in associated hematopoietic
with embryonic-type globin. Lymphopoietic cells and clusters (North et al., 1999). In Ly-6A (Sca-1) green fluo-
hematopoietic progenitors giving rise to adult-type rescence protein (GFP) transgenic mice, GFP was ex-
blood cells are detected in the paraaortic splanch- pressed in all functional HSCs in the midgestation aorta
nopleura (P-Sp) region of mouse embryo at E7.5–9.5 and specifically localized to the endothelial layer lining
(Godin et al., 1995; Delassus and Cumano, 1996). Long- the wall of the dorsal aorta (de Bruijn et al., 2002). These
term repopulating hematopoietic stem cells (LTR-HSCs) results imply the existence of hemogenic endothelial
that can reconstitute adult mice originate from the in- cells and indicate that definitive hematopoietic cells are
traembryonic aorta, gonads, and mesonephros (AGM) of endothelial cell origin.
region at E10.5–11.5 (Muller et al., 1994; Cumano et al., In this study, to identify the role of Notch signaling in
1996; Medvinsky and Dzierzak, 1996). Although a lack HSC development we performed P-Sp organ culture
of the Runx1 (Okuda et al., 1996) or GATA-2 (Tsai et al., using Notch1/ and Notch2/ embryos. Hematopoietic
1994) gene is known to be lethal to the mouse embryos cell development together with angiogenesis was se-
verely impaired in P-Sp of the Notch1/ but not of the
Notch2/ embryo. Although colony forming cell (CFC)*Correspondence: hhirai-tky@umin.ac.jp
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activity in YS was maintained in the Notch1/ mice, bryos were similar or only slightly reduced in size com-
pared to wild-type embryos at the same stage, whereasHSC activity was undetectable in both P-Sp and YS
of the Notch1/ embryo. Since the number of surface E10.5 Notch1/ embryos were markedly reduced in size
and had obvious morphological abnormalities, as de-marker-defined hemogenic endothelial cells did not de-
crease in either YS or P-Sp, we propose that Notch1 scribed previously (Swiatek et al., 1994; Conlon et al.,
1995). We therefore performed in vitro P-Sp organ cul-plays an essential role in preparing endothelial cells for
hematogenicity. ture of the Notch1/ embryo at E9.5 to analyze vas-
culo-angiogenesis and hematopoiesis. In this culture,
PECAM-1() endothelial cells formed a sheet-like struc-Results
ture (vascular bed, vb) and a network structure (vascular
network, vn), which reflect vasculogenesis and angio-Notch Family Proteins Are Differentially Expressed
genesis, respectively (Takakura et al., 1998). Althoughduring Hematopoietic Development
the Notch1/ explant culture was not different from thatIn order to determine the role of Notch signaling in devel-
of wild-type (data not shown), the Notch1/ explantopment of hematopoietic cells, we performed immuno-
culture showed markedly impaired vn formation but littlestaining of the AGM-derived cells with antibodies recog-
defect in vb formation (Figure 2A). This pattern, whichnizing respective Notch family members. Previously, it
demonstrates impaired angiogenesis, was similar to thewas reported that among the Notch family members,
result previously shown in the Runx1/ embryo vascula-only Notch1 and Notch4 are expressed in the endothelial
ture. In this culture system, it was also shown that hema-cells in the AGM region (Villa et al., 2001) and that Notch1
topoietic cell development was severely impaired in theand Notch2 are expressed in hematopoietic stem cells
Notch1/ embryo (Figure 2B). Furthermore, the CFC(Milner et al., 1994; Bigas et al., 1998). Thus, we first
assay using hematopoietic cells from the culturedinvestigated the expression of Notch1, Notch2, and
Notch1/ P-Sp showed that there were few CFCs andNotch4 in the endothelial and hematopoietic cells in the
no mixed colony forming cells (Figure 2C). These resultsP-Sp region at E9.5 before and after the culture. Before
indicate that Notch1 is indispensable for angiogenesisthe culture, Flk1() endothelial cells expressed Notch1
and hematopoietic development from the P-Sp region.and Notch4 (Figure 1A). After a 7 day culture, round-
shaped CD45() hematopoietic cells were produced
that expressed Notch1 and Notch2 but not Notch4 (Fig- CFCs Were Preserved in the YS of Notch1/ Mice
There were obviously reduced but visible red blood cellsure 1B). Endothelial cells at this point continued to ex-
press Notch1 and Notch4 (data not shown). Since 1, 1- in the Notch1/ embryo, which most likely represent
primitive hematopoiesis. Therefore, to examine to whatdioctadecyl-3, 3, 3, 3-tetramethylindo-carbocyanine
perchlorate (Dil-Ac-LDL), which is specifically incorpo- extent the primitive hematopoiesis was preserved, we
investigated the CFC activity in YS of the Notch1/rated by the endothelial cells, was incorporated in the
CD45() hematopoietic cells at this stage, it was indi- embryo. Surprisingly, the numbers and sizes of blood
cell colonies derived from the cells prepared fromcated that these cells were progenies of the endothelial
cells (data not shown) (Hara et al., 1999). Essentially the Notch1/ YS were very similar to those from wild-type
YS, showing only a slight decrease in the total colonysame expression patterns were observed for Notch1,
Notch2, and Notch4 in the cells prepared from E10.5 number (Figure 2D). The number of mixed colonies was
not reduced (Figure 2D). Since we confirmed the expres-AGM before and after the culture (data not shown). We
next stained the whole embryo sections for Notch1 to sion of H1-globin in all colonies individually examined,
they were thought to have originated from primitive he-evaluate its in situ expression around P-Sp and AGM
from E9.5–E11.5 embryos. The aortic wall was stained matopoietic progenitors (data not shown) (Palis et al.,
1999).for Notch1 in these sections throughout these stages.
Notably, in the E11.5 AGM sections, we found specific
staining of a monolayer representing the CD31() aortic The Hemogenic Program Is Impaired
endothelial cells and budding cells from the ventral side in the P-Sp of the Notch1/ Embryo
of the aorta, which are presumably hematopoietic cells To explore the mechanism of impaired hematopoietic
dividing from endothelial cells (Figure 1C). development in the Notch1/ P-Sp, we used a semi-
quantitative RT-PCR method to compare the expression
levels of several transcription factors that were shownBoth Hematopoiesis and Angiogenesis Are Impaired
in the P-Sp Culture from Notch1-Deficient Mice to be essential for various aspects of hematopoiesis
(Figure 3A). The mRNA levels for SCL, Lmo2, GATA-1,Several genes essential for hematopoiesis (for example
SCL, GATA-2, and Runx1) are shown to be expressed GATA-2, and Runx1 were reduced in Notch1/ P-Sp.
These results suggested that the cell-autonomous hem-in both hematopoietic and endothelial cells (Orkin and
Zon, 2002). Since the expression pattern of Notch1 be- ogenic program is impaired in the P-Sp of the Notch1/
embryo.longs to this category, we hypothesized that Notch1
might also be essential for hematopoietic development. To elucidate the mechanism of impaired angiogen-
esis, we analyzed the expression levels of several regu-In mice, Notch1 deficiency arrests development at or
shortly before E9.5, and is embryonic lethal at or soon latory cytokines for angiogenesis and their receptors.
The mRNA levels for all the genes studied, however,after E10.5 because of several defects including angio-
genesis. There is, however, no information about the were unchanged between the Notch1/ P-Sp and the
wild-type P-Sp (Figure 3B). Thus, there was no directhematopoietic development (Swiatek et al., 1994; Con-
lon et al., 1995; Krebs et al., 2000). E9.5 Notch1/ em- evidence suggesting the association of Notch1 signaling
The Role of Notch1 in Definitive Hematopoiesis
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Figure 1. Expression of Notch Family Proteins in the Cells Derived from P-Sp Before and After the Culture and in the AGM Region from Whole
Embryo Sections
Single cells derived from E 9.5 P-Sp were cultured on OP-9 stromal cells and the development of hematopoietic cells was observed.
Immunostaining using control IgG, anti-Notch1, Notch2, and Notch4 antibodies was performed for (A) the Flk1 () endothelial cells at culture
day 1, and (B) the CD45() hematopoietic cells at culture day 7. Magnification, 200. (C) Immunohistochemical staining of frozen section of
the E 11.5 AGM region of a mouse embryo with anti-Notch1 (green) and PECAM-1 (red). Both PECAM-1() endothelial cells and hematopoietic
clusters expressed Notch1. Arrowheads indicate the hematopoietic clusters. Upper panel: lower magnification (20). Upper right and lower
left are located to the ventral and dorsal side of the embryo, respectively. Scale bar, 100 m. Lower panel: higher magnification (100). Scale
bar, 5 m.
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Figure 2. Angiogenesis and Hematopoiesis Were Impaired in the P-Sp Region in the Notch1 Mutant Embryo, but CFC Activity of YS Was
Maintained
P-Sp explants from Notch1/ and Notch1/ embryo at E 9.5 were cultured on OP-9 cells. (A) Endothelial cells at culture day 7 were
immunostained by an anti-PECAM-1 antibody. Upper panel, lower magnification (100); lower panel, higher magnification (200). vb, vascular
bed; vn, vascular network. (B) Hematopoietic cells emerged at day 3 and at day 6 from a Notch1/ P-Sp whereas no hematopoietic cells
were observed in the culture of Notch1/ P-Sp. Magnification, 200. CFC activity of the cells harvested after day 7 from the P-Sp organ
culture (colonies per cultured cells from a P-Sp) (C) and of the cells freshly prepared from YS (colonies per 1  105 cells) (D) from Notch1/
(N1/) and Notch1/ (N1/) embryos. The results show the mean values of triplicate wells with standard deviations in one representative
experiment from three independent experiments. E, erythroid colony; GM, granulocyte-macrophage colony; mix, mixed colony.
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Figure 3. Expression of Hematopoietic Transcription Factors, Endothelial Growth Factors and Their Receptors, and Surface Markers of
Hemangioblasts or Hemogenic Endothelial Cells
Expression of hematopoietic transcription factors (A) and endothelial growth factors and their receptors (B) was analyzed by semiquantitative
RT-PCR to compare the level of expression between the P-Sp of Notch1/ (N1/) and Notch1/ (N1/) embryos.
Expression of surface markers of hemangioblasts or hemogenic endothelial cells was studied by RT-PCR (C) and FACS analysis (D and E).
Representative data in three independent experiments are presented as FACS dot plots, and percentages of cells in each quadrant are
indicated.
with the expression of these genes, although the defi- kawa et al., 1998; Hara et al., 1999; Ogawa et al., 1999;
Sanchez et al., 1996; Marshall et al., 1999; Takakura etciency of Notch1 may have an effect downstream of
these gene products. al., 1998). By a semiquantitative RT-PCR method, we
compared the expression levels of these marker mole-
cules. The results showed that there were no apparentCells Displaying the Phenotypes of Hemangioblast/
Hemogenic Endothelial Cells Are Present differences in the expression levels between the control
(Notch1/) and Notch1/ P-Sp (Figure 3C), suggestingin the Notch1/ Embryo
We next studied whether hemangioblast/hemogenic en- that cells with characteristics of hemogenic endothelial
cells do exist in the Notch1/ embryo.dothelial cells might exist in the Notch1/ embryo. Pre-
viously, several surface proteins were characterized as It was previously shown that HSC activity exists in
the CD34()c-kit() or vascular endothelial (VE)-cadher-markers of these cells present in P-Sp/AGM or YS (Nishi-
Immunity
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Figure 4. Effect of Microenvironmental Signals to the Notch1/ P-Sp
Expression of the genes essential for the generation of hematopoietic cells was analyzed by RT-PCR (A). Dhh, Desert hedgehog; Ihh, Indian
hedgehog; Shh, Sonic hedgehog; and BMP-RIA, BMP type IA receptor. (B) Addition of BMP-4 could not rescue the defect of development
of hematopoietic cells in the Notch1/ P-Sp at E 9.5 organ culture at day 7. Magnification, 200. (C) Normal microenvironment of wild-type
embryo could not rescue the hematopoietic deficiency. Notch1/GFP() embryo was established (upper panel). Mixture of the dissociated
Notch1/GFP(-) P-Sp (E 9.5) (1  105 cells/ml) and Notch1/GFP()P-Sp (1  105 cells/ml) were cultured on OP-9 cells (lower panel). No
GFP() hematopoietic cells were detected at culture day 7.
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in()CD45(-) cells in both YS and P-Sp (Yoder et al., Table 1. In Vivo Hematopoietic Reconstitution by Transplanted Cells
1997; Nishikawa et al., 1998). To identify the cells dis-
Reconstituted/Transplantedplaying surface expression of these markers, single cell Embryonic
suspensions of the YS and P-Sp of the Notch1/ and Tissue Notch1/ Notch1/ Notch1/
Notch1/ embryo were analyzed by flow cytometry. The
YS 1 ee 2/3 4/6 0/3
ratios of CD34()c-kit() and VE-cadherin()CD45(-) 2 ee 3/3 0/2
cells were similar or increased in both YS and P-Sp of the 3 ee 1/1 0/1
Notch1/ embryo compared to those of the Notch1/ P-Sp 1 ee 1/2 3/6 0/3
2 ee 2/4 0/3embryo (Figures 3D and 3E). As the total number of cells
3 ee 1/1 0/1recovered from the individual YS or P-Sp of Notch1/
embryo was reduced to approximately two-thirds Cells from E 9.5 YS and P-Sp were injected into the conditioned
newborn recipients. Transplanted cells were ranged from 1 to 3(range, 0.5–1.0) of those of a Notch1/ embryo, the total
embryo equivalents (ee). At 8–12 weeks after the transplant, donornumbers of CD34()c-kit() and VE-cadherin()CD45
cell contribution was analyzed using the Ly5.2 marker. More than(-) cells were similar in both Notch1/ and Notch1/
1% contribution was determined as positive.YS and P-Sp.
Normal Microenvironment Cannot Rescue the Defect
donor-derived Ly 5.2() cells could be detected in theof Hematopoietic Development in the Notch1/
peripheral blood of the recipients that received P-SpEmbryo Culture
cells from the Notch1/ and Notch1/ but not fromTo explore the possibility that the impaired hematopoie-
the Notch1/ embryos (Table 1), despite the fact that thesis in the Notch1/ mice was due to the lack of environ-
YS cells from the Notch1/ embryos had CFC activity asmental cues essential for hematopoietic development,
Notch1/ and Notch1/ embryos (Figure 2D). Thus,we first analyzed the expression of the candidate genes
Notch1 is required for the generation of HSCs in bothfor these environmental molecules by a semiquantitative
P-Sp and YS.RT-PCR method. Previously, hedgehog and bone mor-
phogenetic protein (BMP) families were shown to be
engaged in this process (Dyer et al., 2001; Winnier et Notch1 Is Essential for the Step of Emergence
al., 1995; Kishimoto et al., 1997). Among them, BMP-4 of Hematopoietic Cells from Endothelial Cells
was downregulated in Notch1/ P-Sp (Figure 4A). To Notch1 has been shown to be essential for hematopoi-
study whether lack of hemogenic potential of Notch1/ etic development. Although this could simply represent
P-Sp was due to impaired BMP-4 production, we added a secondary effect due to markedly impaired angio-
BMP-4 to the P-Sp organ culture. Addition of BMP-4, genesis, it was hypothesized that hemangioblasts, the
however, could not rescue the hemogenic deficiency of common progenitor for endothelial and primitive hema-
the Notch1–/– P-Sp (Figure 4B). topoietic progenitors, might develop normally since vas-
To further assess the involvement of other unidentified culogenesis occurred normally and the CFC activity was
molecules, we cultured a mixture of cells prepared from maintained in YS. Our observation described above also
wild-type and Notch1/GFP() P-Sp. After a 7 day cul- suggested that the cells phenotypically characterized
ture, hematopoietic cells appeared, but all of them were as hemogenic endothelial cells in P-Sp could develop
GFP(-), indicating that the normal environment did not normally in number.
rescue the defect in Notch1/ P-Sp (Figure 4C). There- To investigate the role of Notch signaling after the
fore, it was further indicated that the defect of hemato- establishment of hemogenic endothelial cells, in the
poietic development in Notch1/ embryo is attributed E9.5 wild-type P-Sp organ culture we used the -secre-
not to environmental effects but to the cell-autonomous tase inhibitor, which inhibits the release of the Notch
effect in hemogenic endothelial cells. intracellular domain and mimics the phenotype of condi-
tional knockout mice in the fetal thymic organ culture
(Doerfler et al., 2001; Hadland et al., 2001). AdditionHSC Activity Is Diminished in Both YS and P-Sp
of the Notch1/ Embryo of the -secretase inhibitor significantly impaired the
generation of hematopoietic cells similar to Notch1/Using an irradiated adult mouse as a recipient, definitive
HSC activity is first detectable in the AGM region of the P-Sp (Figure 5A). In the AGM explant culture at E10.5,
however, when CD45() hematopoietic progenitors al-embryo at day 10.5 (Medvinsky et al., 1993; Muller et
al., 1994; Cumano et al., 1996; Medvinsky and Dzierzak, ready exist, the presence of the -secretase inhibitor
did not seem to affect the in vitro generation of hemato-1996). In contrast, when conditioned newborn mice are
used as recipients, HSC activity can be detected as poietic cells (Figure 5A). To find the stage at which Notch
signaling plays a key role, we separated VE-cadher-early as day 8 or 9 in both YS and P-Sp (Yoder et al.,
1997). Because the Notch1/ embryo dies at or soon in()CD45(-) hemogenic endothelial cells from E10.5
AGM and used them for the culture. In this experiment,after E10.5 and showed obvious developmental retarda-
tion after E9, we performed the latter method to deter- addition of the -secretase inhibitor significantly im-
paired the generation of hematopoietic cells in the samemine whether the HSC activity exists in the Notch1/
embryo. manner as was observed in the experiment with the E9.5
P-Sp explant (data not shown). Therefore, the -secre-We transplanted 1 to 3 embryo-equivalent (ee) cells
from E9.5 YS and P-Sp of Notch1/, Notch1/, and tase inhibitor impaired the generation of hematopoietic
cells but did not affect their proliferation or maintenance.Notch1/ embryos (Ly 5.2) into a busulfan conditioned
newborn recipient (Ly 5.1). At 2 months posttransplant, To rescue the -secretase inhibitor-induced repression
Immunity
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Figure 5. Addition of a -Secretase Inhibitor
Mimics the Notch1/ Phenotype and
Notch1IC Rescues the -Secretase Inhibitor-
Induced Block of Hematopoiesis
(A) The -secretase inhibitor significantly im-
paired the development of hematopoietic
cells in the E 9.5 P-Sp organ culture of wild-
type embryo but did not affect the prolifera-
tion or maintenance of hematopoietic cells
from E 10.5 AGM. Development of hemato-
poietic cells was evaluated at culture day 7.
(B) Infection of retrovirus containing
Notch1IC increased the hematopoietic cells
in the presence of the -secretase inhibitor.
Virus-infected cells showed GFP() at culture
day 7.
(C) Histograms of the CD45-stained cells for
the GFP-gated cell populations. Percentages
of CD45() cells are indicated. Left and mid-
dle panels, infection with the control GFP vi-
rus without (left) or with (middle) the -secre-
tase inhibitor. Right panel, infection with the
N1IC vector with the -secretase inhibitor.
Representative data in three independent ex-
periments are presented.
of hematopoietic cell development, the cells from P-Sp of hematopoietic cell production was rescued by the
introduction of constitutive active Notch1.were transduced with an intracellular portion of Notch1
(N1IC), which is constitutively active, using the pMYIR-
ESGFP retrovirus vector that generates a bicistronic
transcript encoding an internal ribosomal entry site Notch2 Is Dispensable for the Development
of Hematopoietic Cells(IRES) and GFP, and cultured in the presence of the
-secretase inhibitor. The transduction efficiencies with Notch2/ mice develop normally until E9.5, and then
around E11.5 lethal, widely distributed, massive cellcontrol and N1IC vectors were almost equal (44% and
45%, respectively) (data not shown). In the control vec- death results (Hamada et al., 1999). We performed in
vitro P-Sp organ culture from the Notch2/ embryotor-transduced group, the addition of the -secretase
inhibitor reduced the ratio of CD45() among the GFP() (E9.5). No difference was observed in the hematopoietic
cell development between the Notch2/ and wild-typefraction at day 7 of culture. In contrast, even in the
presence of the -secretase inhibitor, the N1IC vector- P-Sp (Figure 6A). The CFC activity of hematopoietic cells
from the cultured P-Sp was also maintained (data nottransduced GFP() cells gave rise to round cells indicat-
ing hematopoietic cells (Figure 5B), and most of the cells shown). The CFC activity in YS was not changed be-
tween the wild-type and Notch2/ embryos (Figure 6B).in the GFP() fraction expressed CD45 at a high level,
which is similar to that in the absence of the -secretase Furthermore, the HSC activity was similar in both YS
and P-Sp of the Notch2/ embryo when investigated ininhibitor (Figure 5C). These results indicate that the re-
duction of Notch signaling blocked the generation of the busulfan-conditioned newborn transplantation sys-
tem (data not shown). These results indicate that Notch2hematopoietic cells at E9.5 P-Sp, and that this inhibition
The Role of Notch1 in Definitive Hematopoiesis
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Figure 6. Normal Hematopoietic Develop-
ment in the Notch2/ Embryo
P-Sp organ culture from Notch2/ and
Notch2/ embryos (A). Hematopoietic cells
normally developed from the Notch2/ em-
bryo at culture day 7. Magnification, 200.
(B) CFC activity of YS-derived cells was al-
most the same in wild-type and Notch2/
embryos. The results show the mean values
of triplicate wells with standard deviations in
one representative experiment from three in-
dependent experiments.
is not required for the embryonic development of hema- Bruijn et al., 2000). VE-cadherin is described as being
expressed in endothelial cells. VE-cadherin()CD45(-)topoietic cells.
cells sorted from YS or from the caudal half of the em-
bryo containing P-Sp/AGM have been shown to differen-Discussion
tiate in vitro into endothelial and lymphohematopoietic
progenies (Nishikawa et al., 1998).In this study, we investigated the role of Notch signaling
in the development of hematopoiesis. We have shown In the Notch1/ embryo, hemangioblasts appear to
be intact because neither vasculogenesis in the YS andthat the expression patterns of Notch1, Notch2, and
Notch4 are distinct between endothelial cells and hema- embryo proper nor primitive hematopoiesis are im-
paired, as described here. To date, several investigatorstopoietic cells. Among them, Notch1 is expressed in
both CD45(-) endothelial cells and CD45() hematopoi- have independently defined hemogenic endothelial cell
populations by different sets of cell surface markersetic cells (Figure 1). Since several genes essential for
hematopoiesis (Flk-1, SCL, Lmo2, GATA-2, Runx1, etc.) such as c-kit()CD34() (Sanchez et al., 1996), Flk-1()
(Marshall et al., 1999), Tie-2() (Takakura et al., 1998),are expressed in both endothelial cells and hematopoi-
etic cells, we hypothesized that Notch1 is also a regula- VE-cadherin()CD45(-) (Nishikawa et al., 1998), PCLP-
1()CD45(-) (Hara et al., 1999), and 4-integrin()tor for hematopoiesis.
(Ogawa et al., 1999). In our experiment, c-kit()CD34()
and VE-cadherin()CD45(-) cells are found in both P-SpThe Role of Notch1 in the Development of Definitive
Hematopoietic Cells and YS of the Notch1/ embryo as well as the Notch1/
embryo. Surprisingly, the ratios of these cell populationsHematopoietic cells and vascular cells share common
origins and appear to be closely related in the develop- were not decreased in the Notch1/ YS (Figures 3D
and 3E). Notably, an unexplained increase of themental process. In YS, several reports support the exis-
tence of bipotenital hemangioblasts (Pardanaud et al., c-kit()CD34(-) population in the Notch1/ YS was dem-
onstrated (Figure 3D), although its significance is un-1989; Choi et al., 1998; Jaffredo et al., 1998). In vitro
differentiation of embryonic stem (ES) cells shows their known. Nevertheless, specification into the hemogenic
endothelial cells recognized by these surface markerspresence, although short-lived. In the embryo proper,
HSCs appear to arise from a subset of the vascular is intact in the Notch1/ embryo. It is likely to be capaci-
tating endothelial cells for hematogenicity that is defec-compartment (hemogenic endothelial cells) but only at
limited sites such as the ventral wall of the dorsal aorta tive in the Notch1/ embryo.
Recently, it was reported that Notch pathway mole-and proximal umbilical and vitelline arteries (Pardanaud
et al., 1989; Jaffredo et al., 1998; Tavian et al., 1996; De cules are essential for the maintenance, but not for the
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generation, of mammalian neural stem cells (Hitoshi et of ES cells into hematopoietic lineages (Nakayama et
al., 2002). This could raise the possibility that Notch1 al., 2000; Li et al., 2001) and is expressed at high levels
functions in the maintenance or expansion of HSCs, with a striking polarity in a region of densely packed
rather than their generation. However, both currently cells underlying intra-aortic hematopoietic clusters in
described and previously reported observations conflict the AGM regions (Marshall et al., 2000). These findings
with this possibility. For example, we have shown that suggest that BMP-4 might be a major effector down-
the addition of a -secretase inhibitor significantly im- stream of the Notch signaling. The addition of BMP-4
paired the generation of hematopoietic cells from the to the Notch1/ P-Sp organ culture, however, could not
explanted wild-type E9.5 P-Sp (Figure 5A) and from rescue the development of hematopoietic cells (Figure
E10.5 AGM-derived VE-cadherin()CD45(-) cells (data 4B). This implies that downregulation of BMP-4 expres-
not shown), but not from the explanted wild-type E10.5 sion is not the sole reason for the defect in definitive
AGM, where CD45() hematopoietic cells already exist. hematopoiesis. The expression of other TGF- family
Furthermore, in a previous report using a conditional molecules is intact in the Notch1/ mice (data not
gene targeting system in which Notch1 was disrupted shown).
after birth, Notch1-deficient bone marrow cells contrib- Targeted disruption of various transcription factors
uted normally to all hematopoietic lineages other than indicates that SCL/tal-1 (Porcher et al., 1996), Lmo-2
the T cell lineage in a lethally irradiated adult recipient (Yamada et al., 1998), and GATA-1 (Pevny et al., 1991)
(Radtke et al., 1999). These results indicate that Notch1 are required for both primitive and definitive hematopoi-
acts at the step of the generation but not the expansion esis and that Runx1 (Okuda et al., 1996) and GATA-2
or maintenance of hematopoietic stem cells. (Tsai et al., 1994) are required mainly for definitive hema-
The origin of HSCs is still controversial. An avian (Die- topoiesis, although primitive hematopoiesis may also
terlen-Lievre, 1975) and amphibian (Turpen et al., 1981) be affected to some extent. It is shown in this paper
chimera systems showed that circulating YS-derived that all of these transcription factors are downregulated
hematopoietic cells are rapidly replaced by those of in the Notch1/ P-Sp, indicating that Notch1 at least
intraembryonic origin. More recently, several lines of partially controls and possibly uses these molecules
evidence have shown that in mice, HSCs, which can in the downstream signaling machineries in definitive,
reconstitute to a lethally irradiated adult recipient, exist although not primitive, hematopoiesis. Recently, it was
only in the AGM region in the embryo proper at E 10.5 reported that Runx and Smad proteins function together
while YS cells show comparable activity only after E11 in gene regulation (Zaidi et al., 2002). In the AGM region,
(Medvinsky and Dzierzak, 1996; Muller et al. 1994). Both Runx1 and Smads activated by BMP-4 may constitute
YS and P-Sp cells from E9 embryos, however, provide the active form of a transcriptional complex. GATA-2 is
multilineage reconstitution in conditioned newborn re- expressed in the endothelial cells in the P-Sp/AGM re-
cipients and in secondary adult recipients in mice (Yoder gion (Minegishi et al., 1999) and is also under the control
et al., 1997). Furthermore, high proliferative potential of BMP-4 (Maeno et al., 1996). We previously reported
colony-forming cells (HPP-CFCs) are found exclusively that Notch1 maintains the expression of GATA-2 (Ku-
within the YS at E8.25 (Palis et al., 1999). Therefore, one mano et al., 2001). All these results support the potential
possibility is that these YS-derived newborn reconstitu- relevance between Notch1 and the hematopoietic tran-
table cells seed in the AGM region and acquire the po- scription factors described above, although more pre-
tential as definitive HSCs. The other possibility is that cise molecular mechanisms need to be clarified in the
definitive HSCs are generated de novo in the AGM re- future.
gions. These two possibilities are not necessarily ex-
clusive of each other. Given the reports that the B lym-
The Role of Notch1 in Angiogenesisphopoietic progenitors in YS at E9.5 are enriched in
Notch signaling plays an important role during vascularthe VE-cadherin()CD45(-) population (Nishikawa et al.,
development in mice (Gridley, 2001). Both Notch1 and1998) and that PCLP-1()CD45(-) cells but not CD45()
Notch1/Notch4 double mutant embryos displayed se-cells from AGM region are transplantable (Hara et al.,
vere defects in angiogenic vascular remodeling (Krebs1999), the major reconstitutable cells in both YS and
et al., 2000). Using the P-Sp organ culture system, weP-Sp/AGM are likely to be hemogenic endothelial cells.
have currently shown impaired angiogenesis in theTaking this notion together with our findings that CFC
Notch1/ embryo. Recently, it was reported using theactivity is maintained in E9.5 YS while the newborn re-
same system that Runx1 is involved in vascular remodel-constitutable activity is lost in the Notch1/ embryo, we
ing through the regulation of angiopoietin-1 productionprefer the hypothesis that definitive HSCs are generated
by hematopoietic cells (Takakura et al., 2000). However,de novo in the AGM region in the physiological condition.
addition of the P-Sp-derived hematopoietic cells to theThe microenvironment in AGM is thought to be essen-
Notch1/ P-Sp organ culture cannot rescue angiogen-tial for HSC’s development (Matsuoka et al., 2001; Mar-
esis (data not shown) unlike the observation that hema-shall et al., 1999). Several molecules such as hedgehog
topoietic cells rescue angiogenesis in the Runx1/(Dyer et al., 2001) and BMP family proteins (Winnier
P-Sp organ culture. Moreover, the angiogenic defectet al., 1995; Kishimoto et al., 1997) are reported to be
appears to be more severe in the Notch1/ embryo thaninvolved in the development of hematopoiesis. Among
in the Runx1/ embryo. Nevertheless, the expressionthem, only BMP-4 is downregulated in the P-Sp region
levels of several angiogenic cytokines and their recep-of the Notch1/ embryo. This is consistent with the
tors were unaffected in the Notch1/ embryo (Figurerecent report that overexpression of Delta1, one of the
3B). The reason angiogenesis is impaired in theNotch ligands, induced BMP-4 expression (Endo et al.,
2002). BMP-4 is essential for the in vitro differentiation Notch1/ embryo remains unknown.
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cell labeling, 10 g/ml acetylated low-density lipoprotein labeledNotch2 Is Dispensable for the Development
with Dil-Ac-LDL (Biomedical Technologies) was added for 6 hr atof Hematopoietic Cells
37	C.Since both Notch1 and Notch2 are expressed in HSCs
Immunostaining of sections from frozen embryo (E11.5) was per-
(Bigas et al., 1998), and Notch1 and Notch2 knockout formed as previously described (Sata et al., 2002). In brief, the frozen
mice die at a similar midgestation stage, Notch2-defi- sections were first stained with antibodies (anti-Notch1, anti-CD31)
followed by incubation with FITC or Cy-3-conjugated secondarycient mice may have a defect in HSC function. However,
antibodies. The sections were mounted with the ProLong Antifadeit is clearly shown here that Notch2 is unnecessary for
Kit (Molecular Probes) and observed under a confocal microscopethe hemogenic capacity, which is proven by the in vitro
(FLUOVIEW FV300, Olympus).and in vivo hematopoietic cell production experiments
(Figure 7; data not shown). We can thus conclude that
CFC AssayNotch1 and Notch2 function differently in the context
Fresh total cells from YS or cells that were recovered by pipettingof the development of hematopoiesis.
alone from the P-Sp organ culture were used for CFC assay. Cells
from 1 embryo equivalent P-Sp organ culture or 1 105 cells from YS
Experimental Procedures were seeded in 3 ml of the methylcellulose (Stem Cell Technologies)
supplemented with 100 ng/ml SCF, 10 ng/ml IL3, and 2 U/ml erythro-
Generation of Mice and Embryos poietin (EPO) (gift from Kirin Brewery, Takasaki, Japan). Colony
C57BL6 mice and Notch1 mutant mice (Conlon et al., 1995) were types were scored at culture day 7 by morphological appearance
purchased from Japan SLC and Jackson laboratory. Notch2 mutant and by Wright-Giemsa staining of each colony.
mice were previously generated (Hamada et al., 1999). Transgenic
mice with GFP were a gift from Dr. M. Okabe (Osaka University,
RT-PCR AnalysisOsaka, Japan) (Okabe et al., 1997). Notch1/ GFP () embryos
The procedures for semiquantitative RT-PCR analysis have beenwere obtained from Notch1/ GFP() mice that were generated by
described elsewhere (Kumano et al., 2001). Sequences of specificcrossing Notch1/ and GFP mice. The time at midday (12:00) was
primers used in RT-PCR and PCR conditions can be requested. YStaken to be E0.5 for the plugged mice.
or P-Sp with the same genotype were pooled to prepare the total
RNA.Cell Preparation
Isolated P-Sp/AGM region and YS of E9.5–11.5 were dissociated
by incubation with 250 U/ml dispase (Godo Shusei) for 30 min at Flow Cytometry Analysis
37	C and cell dissociation buffer (Gibco BRL) for 5 min followed by Flow cytometry analysis was performed in a FACScalibur with the
vigorous pipetting. Cellquest program (Becton Dickinson). For surface staining, cell
suspensions from individual P-Sp or YS were incubated on ice in
In Vitro P-Sp Organ Culture and P-Sp/AGM Cell Culture the presence of various mixtures of labeled mAb. The ly5 alleles were
P-Sp organ culture was performed as described previously (Taka- characterized using biotinylated, phycoerythrin (PE)-, or fluorescein
kura et al., 1998) with a minor modification. In brief, P-Sp explants isothiocyanate (FITC)-conjugated antibodies 104.2 (anti-Ly5.2) or
from E9.5 embryo were seeded on OP-9 stromal cells in RPMI1640 A20.17 (anti-Ly5.1). PE-conjugated anti-Gr-1, anti-Mac-1, anti-CD3,
(Sigma) with 10% fetal calf serum (FCS) supplemented with 50 ng/ml and anti-B220 antibodies were used to examine lineage contribu-
stem cell factor (SCF) and 5 ng/ml interleukin3 (IL3) (gifts from Kirin tion. FITC-conjugated anti-CD34, PE-conjugated anti-c-kit, and pu-
Brewery, Takasaki, Japan). BMP-4 (R&D) was added to the P-Sp rified anti-VE-cadherin antibodies were used for the characterization
organ culture of Notch1/ embryo at 100 ng/ml. of YS and P-Sp cells. All antibodies were purchased from Phar-
Single cell suspensions (1  105 cells/ml in the 12-well plate) mingen.
from P-Sp/AGM were also seeded on OP-9 cells in the condition
described for the organ culture. For mixed culture for
Transplantation AssayNotch1/GFP(-) and Notch1/GFP() P-Sp, the single cell culture
Transplantation of cells into busulfan-treated neonatal mice wassystem was used after mixing 1  105 cells from each P-Sp in the
performed as previously described (Yoder et al., 1997) with a slight12-well plate.
modification. In brief, pregnant mice were intraperitonially injected-secretase inhibitor II (CALBIOCHEM) was added to the P-Sp/
with busulfan (Sigma) at 18.75 g/g on pregnancy day 17 and 18.AGM organ culture and single cell suspension culture at 50 M.
Within 24–48 hr after birth, cells from E 9.5 YS or P-Sp ranging from
1 to 3 embryo equivalents were prepared in 25 l PBS and injected
Immunostaining
into the neonatal liver.
Immunostaining was performed as described previously (Yama-
Peripheral blood (PB) was collected from transplanted mice 8–12
guchi et al., 2002) with a minor modification. In brief, cells from P-Sp
weeks after the transplant. Red blood cells were lysed by Red Blood
and AGM or explants from P-Sp were cultured on OP-9 stromal
Cell Lysing Buffer (Sigma). Donor-derived cells were detected by
cells (Takakura et al., 1998). The cultured samples were fixed with
FACS analysis using the ly5.2 marker and lineage contribution was
-20	C methanol for 15 min for immunofluorescence staining or with
evaluated using Gr-1 and Mac-1 (myeloid), CD3 (T cell), and B220
2% paraformaldehyde for 30 min at room temperature for peroxi-
(B cell).
dase staining. Samples were permeabilized with phosphate-buf-
fered saline (PBS) containing 0.1% NP-40 for 10 min and incubated
for 40 min with 5% BSA in PBS for blocking. The cell layer was then Retroviral Transduction
Notch1IC (N1IC) cDNA (Kumano et al., 2001) was subcloned intocovered with goat antibodies against Notch1 and Notch2 (Santa
Cruz Biotechnology), a rabbit antibody against Notch4 (a gift from the retrovirus vector pMY/IRES-EGFP (pMY/IG) (Kitamura et al., in
press), a gift from T. Kitamura (IMSUT, Tokyo). The resulting pMY/Y. Shirayoshi), and rat antibodies against CD45, CD34, CD31
(PECAM-1), and Flk1 (Pharmingen) and incubated for 60 min. The N1IC-IG and mock pMY/IG were transfected into 
MP34 packaging
cells (a gift from Wakunaga Pharm., Hiroshima, Japan), which werewashed cell layer was incubated with a fluorescein isothiocyanate
(FITC)-conjugated anti-goat or anti-rabbit IgG (ICN pharmaceuticals) single cell-sorted for GFP with the FACS Vantage (Becton Dickin-
son). Retrovirus transduction to the P-Sp cells was performed asand Cy-3-conjugated anti-rat IgG (Jackson Immuno Research Labo-
ratories) secondary antibodies for 45 min. For peroxidase staining described previously (Mukouyama et al., 2000). In brief, single cell
suspensions (1  105 cells/ml in the 12-well plate) were incubatedof the samples from P-Sp organ culture, the samples were fixed
and blocked for endogenous peroxidase activity with 4% H2O2 in with viral supernatant, 10 g/ml Polybrene (Sigma), and the set of
cytokine on OP-9 cells. After 48 hr of incubation, virus-containingPBS. Then, they were incubated with anti-CD31 for 60 min, rinsed,
incubated with secondary antibody conjugated with horseradish medium was replaced by standard culture medium. Retrovirus-
infected cells were evaluated by the expression of GFP.peroxidase, rinsed, and stained with DAB for 10 min. For endothelial
Immunity
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